{
    "2019-09-06": [
        [
            {
                "time": "2019-09-06",
                "original_text": "Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs",
                "features": {
                    "keywords": [
                        "AGN",
                        "Opioid",
                        "Settlement",
                        "Line Extension",
                        "EU",
                        "MRK",
                        "JNJ"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-06",
                "original_text": "Health Care Sector Update for 09/06/2019: NTGN, MYOV, VIVE, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "NTGN",
                        "MYOV",
                        "VIVE",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-06",
                "original_text": "Mallinckrodtâ€™s suffers record plunge after report bankruptcy is being considered",
                "features": {
                    "keywords": [
                        "Mallinckrodt",
                        "record plunge",
                        "bankruptcy",
                        "considered"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-06",
                "original_text": "Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation",
                "features": {
                    "keywords": [
                        "Mallinckrodt",
                        "Bankruptcy",
                        "Opioid",
                        "Litigation"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-06",
                "original_text": "How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Opioid",
                        "Case Ruling",
                        "Big Pharma",
                        "Stocks"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}